Table 1.

Patient demographic and transplant characteristics (N=142)

Patient Characteristic		Frequency (%)
Age at transplantation	<20	13 (9%)
(years)	20–39	28 (20%)
	40–59	78 (55%)
	≥60	23 (16%)
		Median age = 47
Gender:	Female	52 (37%)
	Male	90 (63%)
Race:	African American	6 (4%)
	Caucasian	114 (80%)
	Hispanic	7 (5%)
	Other	13 (9%)
	Not available	2 (1%)
Diagnosis	Acute myeloid leukemia	52 (37%)
	Myelodysplastic syndrome	29 (20%)
	Chronic myeloid leukemia	19 (13%)
	Non-Hodgkins lymphoma	13 (9%)
	Acute lymphocytic leukemia	8 (6%)
	Multiple Myeloma	6 (4%)
	Chronic lymphocytic leukemia	3 (2%)
	Aplastic anemia	5 (4%)
	Other	7 (5%)
Donor type	Allogeneic	59 (42%)
	Autologous	17 (12%)
	Unrelated donor	66 (46%)
Conditioning regimen	Reduced intensity regimens (200cGy*)	37 (26%)
	Myeloablative: CY‡/TBI† 12–13.5 Gy	25 (18%)
	Myeloablative: BU⋄, CY only	61 (43%)
	Other myeloablative regimens	19 (13%)
Baseline serum creatinine (mg/dL)	Median (5th to 95th percentile)	0.9 (0.5–1.3)

^*cGy: centigray;

^‡CY: cyclophosphamide;

^⋄BU: busulfan;

^†TBI: total body irradiation